Fact CheckerSign in

NCT06707402Recruiting

The Effects of 24-Weeks Community-based Brisk Walking in People With Parkinson's Disease

The Effects of 24 Weeks Community-based Brisk Walking on Physical Function, Comorbidities, Cognition, Disease Severity, and Health-related Quality of Life in People With Parkinson's Disease.

Source: ClinicalTrials.gov · Last updated 3 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this clinical trial is to investigate if brisk walking can improve walking function in people with Parkinson's disease and what kind of brisk walking intervention that is most effective. The main questions are: If brisk walking can reduce self-perceived walking difficulty What type of exercise intervention is most effective. Researchers will compare a brisk walking group receiving a personalized walking program with a group receiving an activity tracker and a control group. Participants will * be tested at baseline (0 weeks), post the intervention period (24 weeks) and after a follow-up period (48 weeks). * be randomly allocated to one of three groups at baseline. * follow the prescribed intervention they are allocated to.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
129 (estimated)
First submitted
19 Nov 2024
Start date
11 Mar 2025
Primary completion date
1 Aug 2027
Lead sponsor
University of Aarhus
NCT number
NCT06707402

What you commit to

  • Study type: Interventional
  • Planned participants: 129
  • From 11 Mar 2025 to the primary completion date, 1 Aug 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • have another neurological disorder or other disorders that affect gait and balance (e.g., severe arthritis or arthrosis)
  • have dementia (Montreal Cognitive Assessment score \<18)
  • have cardiovascular, respiratory, orthopedic, or metabolic disorders or other medical comorbidities hindering participation in maximal exercise testing.

Other

  • are pregnant
  • are suffering from alcohol abuse (i.e., exceeding ten units per week, according to the Danish Health Authority recommendation
  • have a depression
  • use an activity tracker during exercise
  • performing high-intensity brisk walking three or more times during a week.

Who the study is looking for

  • clinically diagnosed with Parkinson's disease
  • aged ≥40 years
  • Hoehn and Yahr stage ≤3
  • able to independently undertake transportation back and forth from test days and training sessions
  • expectedly able to complete ≥85% of the training sessions
  • experience walking difficulties (the generic walking scale (Walk-12G) score ≥8.5).

Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Aarhus University, Department of Public Health, Sport Science
Coordinator of this site? Confirm its status
Aarhus CDenmarkRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.